supported by the grants from the Natural Science Foundation of Jiangsu Province(No.BK20191174);the Project of Shanghai Municipal Health Commission(No.202240394).
Esophagus cancer(EC)is one of the most aggressive malignant digestive system tumors and has a high clinical incidence worldwide.Magnolol,a natural compound,has anticancer effects on many cancers,including esophageal c...
National Natural Science Foundation of China(grant numbers:82172502 and 81974127).
Background:Amyotrophic lateral sclerosis(ALS)is irreversible and fatal within 3-5 years,with limited options for treatment.It is imperative to develop a symptom-based treatment that may increase the survival of ALS pa...
supported by the National Natural Science Foundation of China(Grant Nos.82022022,31771117,and 82071274);a Project Funded by the Suzhou Science and Technology Program(Grant No.SYS2019068);a Project Funded by the Clinical Research Program of the WuJieping Medical Foundation(Grant No.320.6750.19092-32);a Project Funded by Jiangsu Key Laboratory of Neuropsychiatric Diseases(Grant No.BM2013003);a Project Funded by the Priority Academic Program Development of the Jiangsu Higher Education Institutes(PAPD).
Gefitinib,a well-known epidermal growth factor receptor(EGFR)tyrosine kinase inhibitor for the targeted therapy of lung cancer,induces autophagy in association with drug resistance.However,it remains unclear whether g...